» Articles » PMID: 24166352

The Promoter SNP, but Not the Alternative Splicing SNP, is Linked to Multiple Sclerosis Among Jordanian Patients

Overview
Journal J Mol Neurosci
Date 2013 Oct 30
PMID 24166352
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Multiple sclerosis is a chronic inflammatory autoimmune disease of the human central nervous system. A number of studies with compelling evidence have provided correlation between single nucleotide polymorphisms in interleukin-7 receptor alpha and multiple sclerosis (MS) in several populations. One such variation, rs6897932, is located within the coding region and results in the generation of a soluble receptor, whereas another one, rs11567685, is located in the promoter region and affects gene expression. In this study, we investigated the frequencies of these two SNPs and their association to MS in 200 healthy controls and 200 MS patients based on a simple PCR-RFLP strategy not reported previously. The frequencies of the high risk alleles for both SNPs were in a high range among healthy and MS subjects relative to previous studies. In addition, whereas no association was found between the alternative splicing SNP, rs6897932, and MS, a significant link was found between the promoter SNP, rs11567685, and MS. These results are in contrast to other studies and may have important implications as to the molecular contribution of IL-7Rα in multiple sclerosis.

Citing Articles

Soluble IL-7Rα/sCD127 in Health, Disease, and Its Potential Role as a Therapeutic Agent.

Barros P, Berthoud T, Aloufi N, Angel J Immunotargets Ther. 2021; 10:47-62.

PMID: 33728276 PMC: 7954429. DOI: 10.2147/ITT.S264149.


Association Between IL7R Promoter Polymorphisms and Multiple Sclerosis in Turkish Population.

Simsek H, Geckin H, Sensoz N, List E, Arman A J Mol Neurosci. 2018; 67(1):38-47.

PMID: 30443838 DOI: 10.1007/s12031-018-1205-0.


Variants in the IL7RA gene confer susceptibility to multiple sclerosis in Caucasians: evidence based on 9734 cases and 10436 controls.

Liu H, Huang J, Dou M, Liu Y, Xiao B, Liu X Sci Rep. 2017; 7(1):1207.

PMID: 28446795 PMC: 5430888. DOI: 10.1038/s41598-017-01345-8.

References
1.
Teutsch S, Booth D, Bennetts B, Heard R, Stewart G . Identification of 11 novel and common single nucleotide polymorphisms in the interleukin-7 receptor-alpha gene and their associations with multiple sclerosis. Eur J Hum Genet. 2003; 11(7):509-15. DOI: 10.1038/sj.ejhg.5200994. View

2.
Pandit L, Ban M, Sawcer S, Singhal B, Nair S, Radhakrishnan K . Evaluation of the established non-MHC multiple sclerosis loci in an Indian population. Mult Scler. 2010; 17(2):139-43. DOI: 10.1177/1352458510384011. View

3.
El-Salem K, Al-Shimmery E, Horany K, Al-Refai A, Al-Hayk K, Khader Y . Multiple sclerosis in Jordan: A clinical and epidemiological study. J Neurol. 2006; 253(9):1210-6. DOI: 10.1007/s00415-006-0203-2. View

4.
Alcina A, Fedetz M, Ndagire D, Fernandez O, Leyva L, Guerrero M . The T244I variant of the interleukin-7 receptor-alpha gene and multiple sclerosis. Tissue Antigens. 2008; 72(2):158-61. DOI: 10.1111/j.1399-0039.2008.01075.x. View

5.
Sawcer S, Hellenthal G, Pirinen M, Spencer C, Patsopoulos N, Moutsianas L . Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 2011; 476(7359):214-9. PMC: 3182531. DOI: 10.1038/nature10251. View